News
20 April 2026: QScint Installs iQID NSight Medium
20 April 2026: QScint announces installation of iQID NSight Medium radionuclide imager at the Center for Addiction and Mental Health (CAMH)
Toronto, Canada and Tucson, AZ - April 20, 2026 - QScint Imaging Solutions LLC (QScint), a world-leader in the production of real-time, quantitative radionuclide imagers for radiopharmaceutical therapy research and digital autoradiography in both academia and industry today announced the installation of its iQID NSight Medium particle imager at the Center for Addiction and Mental Health (CAMH) in Toronto.
10 December 2025: QScint Installs iQID Mini
10 December 2025: QScint announces installation of iQID NSight Medium particle imager at LANL
Los Alamos, NM and Tucson, AZ - December 10, 2025 - QScint Imaging Solutions LLC (QScint), a world-leader in the production of real-time, quantitative alpha- and beta-particle imagers for radiopharmaceutical therapy research and digital autoradiography in both academia and industry today announced the installation of its iQID Mini particle imager at Los Alamos National Laboratory (LANL). The installation expands QScint’s world-wide install base to another government laboratory, putting its patented technology in the hands of talented researchers.
30 September 2025: QScint Installs iQID NSight Medium
30 September 2025: QScint announces installation of iQID NSight Medium particle imager at ORNL
Oak Ridge, TN and Tucson, AZ - September 30, 2025 - QScint Imaging Solutions LLC (QScint), a world-leader in the production of real-time, quantitative alpha- and beta-particle imagers for radiopharmaceutical therapy research and digital autoradiography in both academia and industry today announced the installation of its iQID NSight Medium particle imager at Oak Ridge National Laboratory (ORNL). The installation expands QScint’s world-wide install base to another government laboratory, putting its patented technology in the hands of talented researchers.
8 May 2025: QScint Installs iQID Mini
15 September 2024: QScint announces installation of iQID NSight Mini particle imager at University of Florida
Gainesville, FL and Tucson, AZ - May 8, 2025 - QScint Imaging Solutions LLC (QScint), a world-leader in the production of real-time, quantitative alpha- and beta-particle imagers for radiopharmaceutical therapy research and digital autoradiography in both academia and industry today announced the installation of its iQID Mini particle imager at the University of Florida. The installation expands QScint’s world-wide install base to another academic center, putting its patented technology in the hands of talented researchers.
7 March 2025: QScint Installs iQID NSight Mini
7 March 2025: QScint announces installation of iQID NSight Mini particle imager at Centre hospitalier de l’Université de Montréal
Montreal, Quebec, Canada and Tucson, AZ - March 7, 2025 - QScint Imaging Solutions LLC (QScint), a world-leader in the production of real-time, quantitative alpha- and beta-particle imagers for radiopharmaceutical therapy research and digital autoradiography in both academia and industry today announced the installation of its iQID NSight Mini particle imager at Centre hospitalier de l’Université de Montréal (CHUM). The installation marks the second iQID to find a home in Canada.
29 January 2025: QScint Installs iQID NSight Medium
29 January 2025: QScint announces installation of iQID NSight Mini particle imager at UK Essen
Essen, Germany and Tucson, AZ - January 29, 2025 - QScint Imaging Solutions LLC (QScint), a world-leader in the production of real-time, quantitative alpha- and beta-particle imagers for radiopharmaceutical therapy research and digital autoradiography in both academia and industry today announced the installation of its iQID NSight Medium particle imager at Universitätsklinikum Essen. The installation expands QScint’s world-wide install base to an important nuclear medicine research site in Europe.
30 September 2024: QScint awarded Phase II SBIR grant by NIH/NIBIB
30 September 2024: QScint awarded Phase II SBIR grant by NIH/NIBIB
Tucson, AZ - 30 September 2024 - QScint Imaging Solutions LLC (QScint), a world-leader in the production of real-time, quantitative alpha- and beta-particle imagers for radiopharmaceutical therapy research and digital autoradiography in both academia and industry today announced that it has been awarded a Phase II Small Business Innovation Research (SBIR) grant by the NIH and NIBIB to develop “Novel Isotopic Spectroscopy Imaging Tools for Advancing Targeted Alpha Cancer Therapies”.
15 September 2024: QScint Installs iQID NSight Mini
15 September 2024: QScint announces installation of iQID NSight Mini particle imager at PNNL
Richland, WA and Tucson, AZ - September 15, 2024 - QScint Imaging Solutions LLC (QScint), a world-leader in the production of real-time, quantitative alpha- and beta-particle imagers for radiopharmaceutical therapy research and digital autoradiography in both academia and industry today announced the installation of its iQID NSight Mini particle imager at Pacific Northwest National Laboratory (PNNL). The installation expands QScint’s world-wide install base to another government laboratory, putting its patented technology in the hands of talented researchers.
15 July 2024: QScint Attending AAPM 2024 in Los Angeles
15 July 2024: QScint Attending AAPM 2024 in Los Angeles
Tucson, AZ - 15 July 2024 - QScint Imaging Solutions LLC (QScint) will be exhibiting at the American Association of Physicists in Medicine (AAPM) annual meeting in Los Angeles July 21-24. Drop by and see us at Booth 526 to learn how to use an iQID for QA procedures on your brachytherapy seeds and sources! We’ll also be happy to show you how our iQIDs are used in cutting-edge radiopharmaceutical research. Drop by and see us at booth 526.
28 June 2024: QScint Announces Commitment to Environmentally-friendly Packaging
28 June 2024: QScint announces commitment to environmentally-friendly packaging
Tucson, AZ - 28 June 2024 - QScint Imaging Solutions LLC (QScint), a world-leader in the production of real-time, quantitative alpha- and positron-particle imagers for radiopharmaceutical therapy research and digital autoradiography in both academia and industry today announced its commitment to the use of environmentally-friendly packaging for delivering systems, accessories, and spare parts.
QScint President Dr. Brian Miller commented on the new initiative: “At QScint we’ve always employed re-usable containers for shipping and delivering our world-class particle imagers. We’re pleased to announce that we’re expanding our commitment to using environmentally-responsible packaging by now packaging spare parts and accessories in materials made from at least 80% recycled content and reducing the use of plastic packaging where possible. We look forward to continuing to supply and support our customers in an environmentally responsible manner.”
28 May 2024: QScint Installs Prototype iQID Scope
Bern, Switzerland and Tucson, AZ - 28 May 2024 - QScint Imaging Solutions LLC (QScint), a world-leader in the production of real-time, quantitative alpha- and positron-particle imagers for radiopharmaceutical therapy research and digital autoradiography in both academia and industry today announced the installation of its prototype iQID Scope window-chamber particle imager at Universitätsspital Bern. The iQID Scope is aimed to meet the emerging need for real-time, intravital microscopy of radiopharmaceuticals.
24 May 2024: QScint Installs iQID NSight Mega
24 May 2024: QScint announces installation of flagship iQID NSight Mega particle imager at Washington University in St. Louis
St. Louis, MO and Tucson, AZ - May 24 2024 - QScint Imaging Solutions LLC (QScint), a world-leader in the production of real-time, quantitative alpha- and beta-particle imagers for radiopharmaceutical therapy research and digital autoradiography in both academia and industry today announced the installation of its iQID NSight Mega particle imager at Washington University in St. Louis. The installation expands QScint’s world-wide install base to another academic site, putting its patented technology in the hands of talented researchers.
29 March 2024: QScint Installs iQID NSight Mega
29 March 2024: QScint announces installation of flagship iQID Mega particle imager at Thomas Jefferson University
Philadelphia, PA and Tucson, AZ - March 29, 2024 - QScint Imaging Solutions LLC (QScint), a world-leader in the production of real-time, quantitative alpha- and beta-particle imagers for radiopharmaceutical therapy research and digital autoradiography in both academia and industry announced today the installation of its iQID NSight Mega particle imager at Thomas Jefferson University. The installation expands QScint’s world-wide install base to yet another academic institution, highlighting the role of QScint’s technology in supporting fundamental research.
QScint Wins Sponsored Launch at UACI
QScint Imaging Solutions LLC was honored to win a Sponsored Launch at the University of Arizona Center for Innovation (UACI).
